BackMedicinova Overview

Medicinova Other Current Liabilities

Track Medicinova's other current liabilities ($1.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$1.65B

Peer average / median

Loading

Medicinova Other Current Liabilities History

Loading

Medicinova vs. peers: Other Current Liabilities Comparison

Loading

Medicinova Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Medicinova (MNOV) FAQ

Medicinova (MNOV) currently reports a other current liabilities of $1.6B as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Medicinova's other current liabilities history and peer comparisons.

Medicinova's other current liabilities changed from $0 to $1.6B (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medicinova reported $1.6B in other current liabilities as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $1.6B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medicinova, and consider following MNOV for alerts when major investors trade the stock.

Medicinova is classified in the Healthcare sector. On other current liabilities, it currently shows $1.6B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MNOV with unrelated industries.